|
|
Volumn 103, Issue 12, 2011, Pages 920-921
|
|
Estrogen's dual nature? Studies highlight effects on breast cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIESTROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CARCINOGEN;
DIETHYLSTILBESTROL;
ESTROGEN;
TAMOXIFEN;
APOPTOSIS;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL (TOPIC);
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HUMAN;
METABOLISM;
MORTALITY;
NEOPLASM;
NOTE;
POSTMENOPAUSE;
PREMENOPAUSE;
TIME;
ANTINEOPLASTIC AGENTS, HORMONAL;
APOPTOSIS;
BREAST NEOPLASMS;
CARCINOGENS;
CLINICAL TRIALS AS TOPIC;
DIETHYLSTILBESTROL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ESTROGEN ANTAGONISTS;
ESTROGENS;
ESTROGENS, NON-STEROIDAL;
FEMALE;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
POSTMENOPAUSE;
PREMENOPAUSE;
TAMOXIFEN;
TIME FACTORS;
|
|
EID: 80051739195
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr233 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
